Neurotrophic keratopathy and diabetes mellitus

Eye

Volumn 20, Issue 7, 2006, Pages 837-839

  Lockwood, A ^a   Hope Ross, M ^a   Chell, P ^b  

^a CITY HOSPITAL   (United Kingdom)

^b WORCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Keratopathy; Neurotrophic

Indexed keywords

ANTIBIOTIC AGENT; BOTULINUM TOXIN A; CHLORAMPHENICOL; INSULIN; LUBRICATING AGENT; STEROID;

ADULT; ARTICLE; AWARENESS; CASE REPORT; CLINICAL FEATURE; CORNEA ULCER; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EYE PROTECTIVE DEVICE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KERATOPATHY; LASER COAGULATION; OPHTHALMOLOGY; PERIPHERAL NEUROPATHY; TREATMENT OUTCOME; TRIGEMINAL NERVE DISEASE; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

EID: 33748264704     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702053     Document Type: Article

References (18)

1. Hyndiuk RA, Kazarian EL, Schultz RO, Seideman S. Neurotrophic corneal ulcers in diabetes mellitus. Arch Ophthalmol 1977; 95: 2193-2196.
2. Infeld DA, O'Shea JG. Diabetic retinopathy. Postgrad Med J 1998; 74: 129-133.
3. Clark CM, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995; 332: 1210-1217.
4. Bonini S, Rama P, Olzi D, Lambiase A. Neurotrophic keratitis. Eye 2003; 17: 989-995.
5. De Haas EBH. Desiccation of cornea and conjunctiva after sensory denervation. Arch Ophthalmol 1962; 67: 79-92.
6. Shimizu T, Izumi K, Fujita S, Koja T, Sorimachi M, Ohba N et al. Capsaicin-induced corneal lesions in mice and the effects of chemical sympathectomy. J Pharmacol Exp Ther 1987; 243: 690-695.
7. Reid TW, Murphy CJ, Iwahashi CK, Foster BA, Mannis MJ. Stimulation of epithelial cell growth by the neuropeptide substance P. J Cell Biochem 1993; 52: 476-485.
8. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237: 1154-1162.
9. Lambiase A, Rama P, Bomini S, Capriogliio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998; 338: 1174-1180.
10. Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Trans Am Ophthalmol Soc 1981; 79: 180-199.
11. Schultz RO, Peters MA, Sobocinski K, Nassif K, Scultz KJ. Diabetic keratopathy as a manifestation of peripheral neuropathy. Am J Ophthalmol 1983; 96: 368-371.
12. Tsubota K, Chiba K, Shimazaki J. Corneal epithelium in diabetic patients. Cornea 1991; 10: 156-160.
13. Yagihashi S, Kamijo M, Ido Y, Mirrlees D. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Diabetes 1990; 39: 690-696.
14. Kern TS, Engerman RL. Distribution of aldose reductase in ocular tissues. Exp Eye Res 1981; 33: 175-182.
15. Datiles MB, Kador PF, Fukui HN, Hu TS, Kinoshita JH. Corneal re-epithelialization in galactosemic rats. Invest Ophthalmol Vis Sci 1983; 24: 563-569.
16. Hosotani H, Ohashi I, Yamada M, Tsubota K. Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112. Am J Ophthalmol 1995; 119: 288-294.
17. Saito J, Enoki M, Hara M, Morishge N, Chikama T, Nishida T. Correlation of corneal sensation, but not of basal or reflex tear secretion, with the stage of diabetic retinopathy. Cornea 2003; 22(1): 15-18.
18. Murphy PJ, Patel S, Kong N, Ryder REJ, Marshall J. Noninvasive assessment of corneal sensitivity in young and elderly diabetic and nondiabetic subjects. Invest Ophthalmol Vis Sci 2004; 45: 1737-1742.